RT-PCR analysis revealed that among these candidates, MMP-1 exhibited the most significant differential expression (Supplementary Figure 2), identifying it as a target for further investigation to clarify the specific signaling pathway through which AGBL4 may promote GBM tumor progression. The gene discussed is AGBL4; the disease is glioblastoma.